Narcolepsy is a sleep disorder that affects the brain ability to regulate sleep-wake cycles and it can present unique challenges for adolescents Teenagers with narcolepsy experience symptoms like exce ...
Increased levels of Tribbles homolog 2 (TRIB2) autoantibodies, which specifically target hypocretin neurons, have been observed in patients with narcolepsy, and high levels of these antibodies ...
“That’s when we knew these animals had something akin to narcolepsy,” says Willie. The team recruited Thomas Scammell, MD, a Harvard neurologist, to investigate whether modafinil — an anti ...
Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing ...
(CNN) — Matthew Horsnell began falling asleep for no reason when he was in sixth grade. “I would go to bed at 8:30 at night, yet every morning I would wake up and struggle to get out of bed ...
NEWARK, Del, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The Narcolepsy Treatment Market 2024 to 2034 is expected to experience substantial growth, with the market size projected to expand from USD 5,301.6 ...
People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...
Axsome's AXS-12 met its primary endpoint in a Phase 3 study, significantly reducing cataplexy attacks in narcolepsy patients, positioning it for an NDA submission. The narcolepsy market is ...
ENCORE was a multi-center, two-period Phase 3 trial evaluating the long-term efficacy and safety of AXS-12 in patients with narcolepsy with cataplexy, consisting of a 6-month open-label AXS-12 ...